-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VRluwPnvIsVVLhXojUBiGhsMoU+r1vozF2qXBXWdG25Mu3zwa6XhjbB9EnM5A00a 6Xtg9Z8OTwXjqURacfKriw== 0000898430-95-001916.txt : 19951002 0000898430-95-001916.hdr.sgml : 19951002 ACCESSION NUMBER: 0000898430-95-001916 CONFORMED SUBMISSION TYPE: 10-C PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19950920 FILED AS OF DATE: 19950928 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: AGOURON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000811210 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330061928 STATE OF INCORPORATION: CA FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-C SEC ACT: 1934 Act SEC FILE NUMBER: 000-15609 FILM NUMBER: 95576850 BUSINESS ADDRESS: STREET 1: 10350 NORTH TORREY PINES ROAD, SUITE 100 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 6196223000 MAIL ADDRESS: STREET 1: 10350 NORTH TORREY PINES ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 10-C 1 FORM 10-C SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-C REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ INTERDEALER QUOTATION SYSTEM Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and Rule 13a-17 or 5d-17 thereunder AGOURON PHARMACEUTICALS, INC. - ------------------------------------------------------------------------------- (Exact name of issuer as specified in charter) 10350 N. Torrey Pines Road, Suite 100, La Jolla, CA 92037 - ------------------------------------------------------------------------------- (Address of principal executive offices) Issuer's telephone number, including area code (619) 622-3000 -------------------------------- I. CHANGE IN NUMBER OF SHARES OUTSTANDING Indicate any change (increase or decrease) of 5% or more in the number of shares outstanding: 1. Title of securities Common Stock without par value ------------------------------------------------------- 2. Number of shares outstanding before the change 7,359,282 ---------------------------- 3. Number of shares outstanding after the change 10,359,282 ----------------------------- 4. Effective date of change September 20, 1995 -------------------------------------------------- 5. Method of change: Specify method (such as merger, acquisition, exchange, distribution, stock split, reverse split, acquisition of stock for treasury, etc.) Distribution --------------------------------------------------------------------------- Give brief description of transaction Public offering of 3,000,000 shares ------------------------------------- of no par common stock under Form S-3 Registration Statement --------------------------------------------------------------------------- (No. 33-61573). PaineWebber Incorporated and Robertson, Stephens & Company, --------------------------------------------------------------------------- L.P. acted as representatives for the Underwriters. --------------------------------------------------------------------------- --------------------------------------------------------------------------- II. CHANGE IN NAME OF ISSUER 1. Name prior to change ------------------------------------------------------ 2. Name after change --------------------------------------------------------- 3. Effective date of charter amendment changing name ------------------------- 4. Date of shareholder approval of change, if required ----------------------- Date: September 28, 1995 Steven S. Cowell ---------------------- ------------------------ Steven S. Cowell Vice President, Finance and Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----